Covid Lockdown Restrictions Mixed China Data and Vaccine Optimism
Signs that China’s economic recovery is gaining momentum, plus covid vaccine optimism, coupled with US fiscal stimulus hopes are just about offsetting fears of rising covid cases in Europe and tighter lockdown restrictions.
Share this:
Whilst the FTSE looks set to lag behind its peers EU bourses are pointing to a mildly stronger start following an upbeat session in Asia with stocks being propelled up towards recent 2.5 year high. Signs that China’s economic recovery is gaining momentum, plus covid vaccine optimism, coupled with US fiscal stimulus hopes are just about offsetting fears of rising covid cases in Europe and tighter lockdown restrictions.
China’a GD revealed growth of 4.9% in the third quarter, just slightly missing expectations of 5.2% growth, although still faster than 3.2% economic growth achieved in Q2. Despite the disappointing print, there were some encouraging signs with an upturn in consumption and continued strength in the factory sector. The monthly indicators actually beat forecasts suggesting that the recovery is picking up momentum boding well for the coming quarter and hopes that China will be able to help haul the globally economy back onto its feet.
Vaccine optimism
Hopes of a vaccine are lifting spirits at the start of the week. Pfizer announced on Friday that a vaccine could be ready before the end of the year. Given that a vaccine is the surest and quickest way to return economic growth to pre-covid levels any hint of vaccine hope often boosts risk sentiment, lifting demand for riskier assets such as stocks. However, with recent disappointment from Johnson & Johnson & Eli Lilly the market is aware that the road to a vaccine is unlikely to be a smooth one.
Fiscal stimulus
Stateside the subject of US fiscal stimulus “will they won’t they” seesaw continues. The latest comments from House Speaker Nancy Pelosi indicates that the Democrats and Republicans could still reach a deal before the US elections. The fact that Trump is also pushing for a deal over $2 trillion, certainly closer to the Democrats $2.2 trillion package demand is also helpful. Although he will still need to convince hawks among the Republicans.
Lockdown restrictions to cap upside
Concerns over rising covid cases are capping gains. The UK recorded over 16,000 new daily infections as large parts of the country experienced tighter lockdown restrictions and as data revealed that the UK experienced a record number of shop closures during the first half of 2020. With Britain facing increasingly stricter lockdown restrictions heading into winter, in addition to a less generous jobs support package from the government the outlook remains very bleak.
Concerns over rising covid cases are capping gains. The UK recorded over 16,000 new daily infections as large parts of the country experienced tighter lockdown restrictions and as data revealed that the UK experienced a record number of shop closures during the first half of 2020. With Britain facing increasingly stricter lockdown restrictions heading into winter, in addition to a less generous jobs support package from the government the outlook remains very bleak.
House builders in focus as house prices surge
House builders will once again be in focus as UK house prices continue to surge through October. Another surge in demand for housing pushed up prices by the most in four years. Buyers are proving to be prepared to pay a premium for more space after their lockdown experience. The housing market is clearly in an extraordinary place right now, but with clouds gathering on the horizon as unemployment is set to surge, the strength in the housing market is unlikely to last into next year.
FTSE Chart
Whilst the FTSE looks set to lag behind its peers EU bourses are pointing to a mildly stronger start following an upbeat session in Asia with stocks being propelled up towards recent 2.5 year high. Signs that China’s economic recovery is gaining momentum, plus covid vaccine optimism, coupled with US fiscal stimulus hopes are just about offsetting fears of rising covid cases in Europe and tighter lockdown restrictions.
China’a GD revealed growth of 4.9% in the third quarter, just slightly missing expectations of 5.2% growth, although still faster than 3.2% economic growth achieved in Q2. Despite the disappointing print, there were some encouraging signs with an upturn in consumption and continued strength in the factory sector. The monthly indicators actually beat forecasts suggesting that the recovery is picking up momentum boding well for the coming quarter and hopes that China will be able to help haul the globally economy back onto its feet.
Vaccine optimism
Hopes of a vaccine are lifting spirits at the start of the week. Pfizer announced on Friday that a vaccine could be ready before the end of the year. Given that a vaccine is the surest and quickest way to return economic growth to pre-covid levels any hint of vaccine hope often boosts risk sentiment, lifting demand for riskier assets such as stocks. However, with recent disappointment from Johnson & Johnson & Eli Lilly the market is aware that the road to a vaccine is unlikely to be a smooth one.
Fiscal stimulus
Stateside the subject of US fiscal stimulus “will they won’t they” seesaw continues. The latest comments from House Speaker Nancy Pelosi indicates that the Democrats and Republicans could still reach a deal before the US elections. The fact that Trump is also pushing for a deal over $2 trillion, certainly closer to the Democrats $2.2 trillion package demand is also helpful. Although he will still need to convince hawks among the Republicans.
Lockdown restrictions to cap upside
Concerns over rising covid cases are capping gains. The UK recorded over 16,000 new daily infections as large parts of the country experienced tighter lockdown restrictions and as data revealed that the UK experienced a record number of shop closures during the first half of 2020. With Britain facing increasingly stricter lockdown restrictions heading into winter, in addition to a less generous jobs support package from the government the outlook remains very bleak.
Concerns over rising covid cases are capping gains. The UK recorded over 16,000 new daily infections as large parts of the country experienced tighter lockdown restrictions and as data revealed that the UK experienced a record number of shop closures during the first half of 2020. With Britain facing increasingly stricter lockdown restrictions heading into winter, in addition to a less generous jobs support package from the government the outlook remains very bleak.
House builders in focus as house prices surge
House builders will once again be in focus as UK house prices continue to surge through October. Another surge in demand for housing pushed up prices by the most in four years. Buyers are proving to be prepared to pay a premium for more space after their lockdown experience. The housing market is clearly in an extraordinary place right now, but with clouds gathering on the horizon as unemployment is set to surge, the strength in the housing market is unlikely to last into next year.
FTSE Chart
Related tags:
Latest market news
The complete CFD trading experience
Award-winning platforms, competitive spreads, low commissions and dedicated support.
We live and breathe the markets and are dedicated to helping traders realise their ambitions as we continue to set the industry bar.
Economic calendar
Web Trader platform
Our sophisticated web-based platform is packed with features.
Related articles
EUR/USD, FTSE 100 Forecast: Two trades to watch 1507
EUR/USD rises after weaker US CPI, PPI up next. FTSE 100 falls as weak China GDP data hits miners.
FTSE 100, USD/JPY Forecast: Two trades to watch
FTSE eases modestly despite inflation unexpectedly holding steady. USD/JPY drifts lower ahead of the FOMC rate decision.
EUR/USD, FTSE 100 Forecast: Two trades to watch 21-05-26
EUR/USD slips below 1.16 as weak eurozone data weighs on sentiment. FTSE 100 slips as oil prices rebound and caution returns.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.